Trials / Completed
CompletedNCT06010680
A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers
Phase I Clinical Trial of Substance Balance of [14C]SHR2554 in Healthy Chinese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the Mass Balance of \[14C\]SHR2554 in Healthy Adult Male Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]SHR2554 | Patients will receive single dose of orally \[14C\]SHR2554 on Day 1. |
Timeline
- Start date
- 2023-10-07
- Primary completion
- 2023-11-27
- Completion
- 2023-11-27
- First posted
- 2023-08-24
- Last updated
- 2024-02-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06010680. Inclusion in this directory is not an endorsement.